Latest tumor Stories
30mg/m2 dose cohort had been completed; enrollment of 40mg/m2 cohort has been initiated VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2014 /PRNewswire/ --
First Case Study Announced While Broader Data Being Collected; Evidence Indicates Substantial Tumor Necrosis and Initial Tumor Regression BETHESDA, Md., May 15, 2014 /PRNewswire/ --
Comprehensive Molecular Profiling Provides Oncologists Treating Patients with Rare, Aggressive or Refractory Cancers with Better Understanding of How to Treat Cancer IRVING, Texas, May 15,
WHIPPANY, N.J., May 14, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
SAN DIEGO, May 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.
MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage.
Clinicians detail how the Edge(TM) radiosurgery suite and other cancer treatment technologies from Varian Medical Systems are enabling fast, precise tumor targeting MINNEAPOLIS, May
Xtalks presents an informative webinar that will discuss the use of image analysis technology to characterize the tumor microenvironment.
New Prognostic Biopsy Test Is Designed To Guide Individual Treatment Decisions About Prostate Cancer CAMBRIDGE, Mass., May 6, 2014 /PRNewswire/ -- Metamark Genetics, Inc.
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.